Clinical trials evaluated AOD-9604 for durations ranging from single doses to 24 weeks of continuous daily administration
At AH-Clinics, we can design a personalized combination of peptides according to your specific health requirements
Semaglutide produced less weight loss than tirzepatide head-to-head, about 14% versus 20%. Its body-composition substudy measured a roughly 62:38 fat-to-lean loss split by mass, compared with about 75:25 for tirzepatide in a separate trial. The scan overstates muscle loss because lean mass includes water and organ tissue
Aronne LJ, Sattar N, Horn DB, et al
Another study found nicotinamide mononucleotide (NMN) improved muscle insulin sensitivity and metabolic signaling in postmenopausal women (NIH)
Beyond its role in reducing oxidative stress, glutathione (GSH) supplementation has been linked to improved insulin sensitivity (how effectively the body responds to insulin), which is associated with a reduced risk of diabetes